Michal Geva

Michal has 20 years of professional experience in Israeli and American medical device companies.

Michal has co-led and founded all of Triventures funds with strategic and financial investors. She has led investments in the fields of structural heart, orthopedics, robotics, women’s health, ophthalmology and digital health. Michal’s investments have been from pre-seed all the way to late stage deals.

Prior to Triventures, Michal held executive roles in regulatory and clinical affairs and in business development at a number of startups including ByPass (collaborated with J&J), AST (acquired by Boston Scientific), and GI View (in the field of gastroenterology).